Stock Report

All about this stock under one free report Last Updated: 03-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

NeuroMetrix (NURO) Key Ratios

Stock Card factsheet share-fund-plan-icon

$4.58

$0.00 (0.00%)

As on 09-May-2025 09:30EDT

Market cap

info icon

$9 Mln

Revenue (TTM)

info icon

$3 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 0.00 -46.70 -52.14 -33.04 -21.24
EBIT 9.04 41.23 13.83 -168.00 -0.88
Net Profit 0.00 41.24 17.88 -139.99 -0.24
EPS 3.95 48.07 45.41 -193.38 8.26
Book Value -- -- -44.86 -7.06 32.09
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-24Dec-23
EBIT-Margin info -89.31-58.67-289.77---121.18
Net Margin info ---27.13-259.97----
Return on equity info -31.40-32.23-43.29-45.38-30.06
Return on Capital info -31.02-30.38---44.93-29.65
Return on Assets info -29.48-25.75-24.81-42.48-28.33
Debt to Equity (x) info ----0.000.010.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
-44.93
-29.65
-18.49
-15.09
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-43.29

Lower than Peers by 48.24

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
-43.29
-45.38
-30.06
-18.75
-15.49
Peer Median
4.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-24.81

Lower than Peers by 27.27

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
-24.81
-42.48
-28.33
-17.62
-13.41
Peer Median
2.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-289.77

Lower than Peers by 298.24

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
-289.77
--
-121.18
-57.43
-27.68
Peer Median
8.47
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-259.97

Lower than Peers by 264.65

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
-259.97
-257.38
-110.64
-52.90
-26.72
Peer Median
4.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-52.14

Lower than Peers by 60.63

Year on year growth in net sales

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
-52.14
-0.49
-0.29
0.00
0.12
Peer Median
8.49
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

13.83

Higher than Peers by 3.18

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
13.83
--
-50.82
-107.55
-9.06
Peer Median
10.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

17.88

Higher than Peers by 4.33

Year on year growth in profit after tax

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
17.88
-19.55
-49.51
-98.05
-10.13
Peer Median
13.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

45.41

Higher than Peers by 24.91

Year on year growth in earnings per share

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
45.41
0.07
0.06
-4.29
-0.63
Peer Median
20.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-32.57

Lower than Peers by 39.58

Year on year growth in book value per share

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
-32.57
--
--
--
--
Peer Median
7.01
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
0.01
0.01
0.02
0.01
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
0.01
0.01
0.01
0.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

14.83

Higher than Peers by 12.00

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
14.83
14.83
16.81
21.79
17.71
Peer Median
2.83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

13.50

Higher than Peers by 11.45

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
13.50
13.50
15.55
20.33
17.19
Peer Median
2.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
--
--
-14.58
-725.27
Peer Median
4.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

7.65

Lower than Peers by 8.81

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
7.65
6.36
8.79
7.83
3.77
Peer Median
16.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.10

Lower than Peers by 0.41

Sales / Average Total Assets

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
0.10
0.17
0.26
0.33
0.50
Peer Median
0.50
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
42.86
36.07
21.18
14.27
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
392.32
296.69
169.19
137.67
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
78.12
54.54
47.53
33.39
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
357.06
278.21
142.85
118.55
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
-1.00
-0.84
-0.33
-5.84
Peer Median
44.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.66

Lower than Peers by 3.13

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
0.66
0.55
0.27
0.06
0.55
Peer Median
3.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

1.46

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
1.46
0.59
1.73
4.14
4.25
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

9

Lower than Peers by 531

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
NeuroMetrix (NURO)
9
--
--
--
--
Peer Median
540
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...